Literature DB >> 15468377

Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.

Athimalaipet V Ramanan1, Norman D Rosenblum, Brian M Feldman, Ronald M Laxer, Rayfel Schneider.   

Abstract

Systemic-onset juvenile rheumatoid arthritis (SoJRA) constitutes about 10-20% of all JRA. However more than two-thirds of the mortality seen in JRA patients is accounted for by SoJRA. Macrophage activation syndrome (MAS), which can also be considered as a form of secondary hemophagocytic lymphohistiocytosis, is a major cause of morbidity and mortality in children with SoJRA. MAS is characterized by persistent high fever, pancytopenia, mild to serious derangements of liver cell function, encephalopathy, and disseminated intravascular coagulation. Renal involvement in MAS is a rarely recognized feature. In 2 recently reported case series of MAS in SoJRA, renal involvement appeared to be associated with poor prognosis. We describe 3 children with SoJRA who had renal involvement complicating MAS and had a favorable outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15468377

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.

Authors:  Mayan Gilboa; Gil Bornstein; Ilan Ben-Zvi; Chagai Grossman
Journal:  Rheumatol Int       Date:  2019-07-31       Impact factor: 2.631

2.  Association of Macrophage Activating Syndrome with Castleman's Syndrome in Systemic Lupus Erythematosus.

Authors:  Shamsa Shariatpanahi; Shahryar Pourfarzam; Mohammadhosein Gheini
Journal:  Iran J Pathol       Date:  2016

Review 3.  Macrophage Activation Syndrome.

Authors:  Ethan S Sen; Sarah L N Clarke; Athimalaipet V Ramanan
Journal:  Indian J Pediatr       Date:  2015-09-24       Impact factor: 1.967

4.  Clinical characteristics of children with MIS-C fulfilling classification criteria for macrophage activation syndrome.

Authors:  Piotr Buda; Ewa Strauss; Danuta Januszkiewicz-Lewandowska; Ewa Czerwinska; Kamila Ludwikowska; Leszek Szenborn; Ewelina Gowin; Magdalena Okarska-Napierała; Ernest Kuchar; Janusz Ksia Zyk
Journal:  Front Pediatr       Date:  2022-09-15       Impact factor: 3.569

Review 5.  Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Authors:  V Boom; J Anton; P Lahdenne; P Quartier; A Ravelli; N M Wulffraat; S J Vastert
Journal:  Pediatr Rheumatol Online J       Date:  2015-12-03       Impact factor: 3.054

6.  Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis.

Authors:  Hua-Song Zeng; Xiao-Yan Xiong; Yan-Dan Wei; Hong-Wei Wang; Xiao-Ping Luo
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.